Form 4: UnitedHealth Group CEO Andrew Witty Reports Stock Transactions
SEC Form 4
Andrew Witty, CEO of UnitedHealth Group, reports acquisition and disposal of common stock and non-qualified stock options.
Summary
- Andrew Witty, CEO of UnitedHealth Group, filed a Form 4 detailing changes in beneficial ownership.
- On February 20, 2025, Witty acquired 15,652 shares of common stock through the settlement of Performance Share Awards and 11,445 shares of restricted stock units.
- Also on February 20, 2025, Witty disposed of 7,356.44 shares of common stock at $502.42.
- On February 21, 2025, Witty disposed of 1,364.164, 1,232.399 and 1,315.23 shares of common stock at $466.42.
- Witty also acquired 48,540 non-qualified stock options on February 20, 2025, exercisable starting February 20, 2026.
- Following these transactions, Witty beneficially owns 112,048.364 shares of common stock and 48,540 non-qualified stock options.
Sentiment
Score: 6
Explanation: The sentiment is neutral. The filing reflects routine transactions related to executive compensation and does not inherently indicate positive or negative sentiment about the company's future performance.
Positives
- Acquisition of 15,652 shares through Performance Share Awards indicates achievement of performance goals.
- Grant of 11,445 restricted stock units and 48,540 non-qualified stock options aligns Witty's interests with shareholders through long-term incentives.
Negatives
- Disposal of 11,268.23 shares of common stock could be interpreted negatively, although it may be for tax purposes related to the vesting of awards.
Future Outlook
The restricted stock units and non-qualified stock options vest annually from 2026 through 2029, indicating continued alignment of executive compensation with long-term company performance.
Industry Context
Form 4 filings are routine disclosures for corporate insiders and provide transparency into their trading activities. These filings are closely watched by investors to gauge management's sentiment and confidence in the company's prospects.
Stakeholder Impact
- The transactions may have a minor impact on shareholders by slightly diluting or increasing the number of outstanding shares.
- The vesting of restricted stock units and stock options incentivizes the CEO to focus on long-term value creation, benefiting shareholders.
Key Dates
| Date | Description |
|---|---|
| 2022 2024 | Performance period for Performance Share Awards. |
| 02/20/2025 | Date of earliest transaction, including acquisition and disposal of common stock and grant of stock options. |
| 02/20/2026 through 2029 | Vesting period for restricted stock units and non-qualified stock options. |
| 02/20/2035 | Expiration date for non-qualified stock options. |
| 02/24/2025 | Date of signature by Attorney-in-Fact. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.